Cargando…

Profile EpicentRx, Inc

Detalles Bibliográficos
Autor principal: Oronsky, Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054294/
https://www.ncbi.nlm.nih.gov/pubmed/36915959
http://dx.doi.org/10.1080/21645515.2023.2184963
_version_ 1785015636977516544
author Oronsky, Bryan
author_facet Oronsky, Bryan
author_sort Oronsky, Bryan
collection PubMed
description
format Online
Article
Text
id pubmed-10054294
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-100542942023-03-30 Profile EpicentRx, Inc Oronsky, Bryan Hum Vaccin Immunother Immunotherapy - Cancer Taylor & Francis 2023-03-13 /pmc/articles/PMC10054294/ /pubmed/36915959 http://dx.doi.org/10.1080/21645515.2023.2184963 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Immunotherapy - Cancer
Oronsky, Bryan
Profile EpicentRx, Inc
title Profile EpicentRx, Inc
title_full Profile EpicentRx, Inc
title_fullStr Profile EpicentRx, Inc
title_full_unstemmed Profile EpicentRx, Inc
title_short Profile EpicentRx, Inc
title_sort profile epicentrx, inc
topic Immunotherapy - Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054294/
https://www.ncbi.nlm.nih.gov/pubmed/36915959
http://dx.doi.org/10.1080/21645515.2023.2184963
work_keys_str_mv AT oronskybryan profileepicentrxinc